Want to strengthen your obesity counseling skills? Practice realistic patient conversations and receive personalized feedback with CaseCoach: rebrand.ly/9454CCSM
In aHUS, delayed diagnosis can have serious consequences. Early recognition is key. Read about how our education can help: rebrand.ly/9484CM#RareDisease#aHUS
This is your last chance to get CE credit from our activity on fibrosing ILDs. Don’t miss out on improving diagnosis, management, and staying current with emerging therapies.
Advancing DMD care means more than new therapies; it means evolving ways to use existing ones. Read about it on our website: rebrand.ly/9470CM#RareDisease#DMD
Many children with #ITP don't require treatment, even with very low platelet counts. How do you determine who does? Listen to this overview of pediatric ITP management: rebrand.ly/9444YTPOD
In DMD, every treatment decision matters. Explore how evolving corticosteroid use impacts care and what we’re doing to prepare clinicians accordingly: rebrand.ly/9470CM#DMD#RareDisease
aHUS is rare, but often misdiagnosed in pregnancy due to overlap with HELLP & TTP. Learn how our education is improving recognition and differentiation: rebrand.ly/9484CM#aHUS#MaternalHealth
New rebalancing therapies are reshaping hemophilia care by restoring clotting balance rather than replacing missing factors. Learn the science and clinical implications in this free CE activity: rebrand.ly/9390SM
Asthma and COPD may share symptoms, but their immunologic drivers differ. Learn how emerging biologic therapies are changing treatment approaches in obstructive lung disease. rebrand.ly/9393SM
Fibrosing ILDs like IPF & PPF are often diagnosed too late. Improve early recognition diagnostic confidence with this case-based CE activity: rebrand.ly/9394SM